Chemical neurotoxins as denervation tools in neurobiology.
D015115:5,6-Dihydroxytryptamine / Q000494:pharmacology; D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology; D000818:Animals; D001596:Benzylamines / Q000494:pharmacology; D001921:Brain / Q000187:drug effects; D002395:Catecholamines / Q000502:physiology; D003714:Denervation / Q000379:methods*; D004298:Dopamine / Q000378:metabolism; D005971:Glutamates / Q000502:physiology; D006801:Humans; D006892:Hydroxydopamines / Q000378:metabolism / Q000494:pharmacology; D007051:Ibotenic Acid / Q000494:pharmacology; D007608:Kainic Acid / Q000494:pharmacology; D009498:Neurotoxins / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000502:physiology*; D010300:Parkinson Disease / Q000378:metabolism; D051381:Rats; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D012559:Schizophrenia / Q000378:metabolism; D012701:Serotonin / Q000502:physiology; D010133:p-Chloroamphetamine / Q000494:pharmacology
D001596:Benzylamines; D002395:Catecholamines; D005971:Glutamates; D006892:Hydroxydopamines; D009498:Neurotoxins; D018377:Neurotransmitter Agents; D017981:Receptors, Neurotransmitter; D007051:Ibotenic Acid; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D010133:p-Chloroamphetamine; C012102:DSP 4; D007608:Kainic Acid; D004298:Dopamine; D015115:5,6-Dihydroxytryptamine